# Corneal Findings in Patients Treated With Belantamab Mafodotin

> **NCT05833737** · — · TERMINATED · sponsor: **Medical University of Vienna** · enrollment: 12 (actual)

## Conditions studied

- Multiple Myeloma
- Corneal Diseases
- Corneal Cyst

## Interventions

- **DRUG:** Belantamab mafodotin

## Key facts

- **NCT ID:** NCT05833737
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-06-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study medication market withdrawal by FDA.
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05833737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05833737, "Corneal Findings in Patients Treated With Belantamab Mafodotin". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05833737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*